Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Graybug Vision Inc (GRAY)

Graybug Vision Inc (GRAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Graybug Vision Inc 203 REDWOOD SHORES PARKWAY SUITE 620 REDWOOD CITY CA 94065 USA

www.graybug.vision P: 650-487-2800

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Graybug Vision Inc. is a clinical-stage biopharmaceutical company. It is focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve. The company's product candidate includes GB-102, GB-401 and GB-103 which are in clinical stage. Graybug Vision Inc. is headquartered in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 8,638
Enterprise Value, $K -30,482
Shares Outstanding, K 1,571
Float, K 1,446
% Float 92.06%
Short Volume Ratio 0.51
% of Insider Shareholders 7.94%
% of Institutional Shareholders 49.94%

Financials:

Annual Sales, $ 506,157 K
Annual Net Income, $ -35,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,400 K

Growth:

1-Year Return -69.31%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 11/10/22
Next Earnings Date 03/23/23
Earnings Per Share ttm -1.32
EPS Growth vs. Prev Qtr -21.05%
EPS Growth vs. Prev Year -21.05%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 03/20/23

GRAY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -77.61%
Return-on-Assets % -71.34%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.24
Book Value/Share 1.67
Interest Coverage 0.00
60-Month Beta 1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar